Clinical Trials and Research

BackgroundCardiac amyloidosis is an infiltrative cardiomyopathy characterized by restrictive physiology and progressive heart failure. Pericardial calcification is…

Transthyretin amyloidosis (ATTR) is a disease where the normally occurring transthyretin (TTR) protein falls apart and forms amyloid, a sticky plaque- like…

Amyloidosis is a rare disease involving the formation and spread of abnormal proteins in the body. Unlike with other proteins, the body cannot naturally recycle…

PurposeAmyloid positron emission tomography (PET) tracers are increasingly used to detect cardiac amyloidosis (CA). 11C-Pittsburgh compound B (PiB) and 1⁸F-…

CAMBRIDGE, Mass. - Alnylam Pharmaceuticals (NASDAQ:ALNY) announced Tuesday partnerships with Viz.ai and the American Heart Association aimed at improving early…

AbstractBackgroundLight-chain amyloidosis (AL) is a rare plasma cell disorder characterized by extracellular deposition of misfolded light chains in multiple organs…

1 research study open to eligible peoplehATTR is a genetic condition where faulty transthyretin protein builds up as amyloid. UCSF is carrying out an observational…

AL amyloidosis is when abnormal proteins called light chains collect in organs. UCSF is studying a drug for people with relapsed or refractory multiple myeloma or…

a study on AL AmyloidosisAmyloidosisOpen-label Phase 1b/2 study with primary objective of this study is to evaluate the safety, tolerability and efficacy of AZD0120…

AbstractAmyloidosis is a systemic disease characterized by the extracellular deposition of the misfolded proteins resulting in organ dysfunction, frequently the…